I have my doubts about that - this stuff is viewed as cutting-edge, and hospitals are likely reluctant to give it up even if it can be done more cost-effectively elsewhere.
I guess we will find out.
I think there are some cases, such as during surgery, where having an in-house team to do rapid staining of sections to gauge margins is worth the expense. But I don't see time as the issue in these DNA diagnostic tests. Over here, I think the infrastructure we have to do these things is more a turf war than a real cost-efficiency calculation.
Agree with your view on sequencing. Eventually it's going to be a routine work-up for all diseases.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.